Skip to main content
. 2022 Jun 10;13:890543. doi: 10.3389/fimmu.2022.890543

Table 1.

Characteristics of the study and comparison population at baseline.

Uveitis
Total With Without P
n % n % n %
Total 5,555 1,111 20 4,444 80
Gender 0.999
Male 3,105 55.9 621 55.9 2,484 55.9
Female 2,450 44.1 490 44.1 1,960 44.1
Age (years) 37.70 ± 19.75 37.66 ± 19.10 37.71 ± 19.91 0.91
Age group (yrs) 0.999
20-39 3,315 59.68 663 59.68 2,652 59.68
40-59 1,560 28.08 312 28.08 1,248 28.08
≧60 680 12.24 136 12.24 544 12.24
Comorbidities
DM 1,398 25.17 275 24.75 1,123 25.27 0.689
Hyperlipidemia 317 5.71 63 5.67 254 5.72 0.911
HTN 1,143 20.58 230 20.7 913 20.54 0.892
COPD 879 15.82 176 15.84 703 15.82 0.952
Asthma 1,043 18.78 208 18.72 835 18.79 0.919
Medications
Systemic Steroids 1,016 18.29 205 18.45 811 18.25 0.900
CCI_R 0.96 ± 1.12 0.92 ± 1.11 0.284

P, Chi-square/Fisher exact test on category variables and t-test on continue variables.